Last update 23 Jan 2025

NET x Orexin receptor

Basic Info

Related Targets
NETOrexin receptor

Related

1
Drugs associated with NET x Orexin receptor
AD-182
Target
NET x Orexin receptor
Mechanism
NET inhibitors [+1]
Active Org.-
Originator Org.
Apnimed, Inc.Apnimed, Inc.Startup
Active Indication-
Inactive Indication
Sleep Apnea, Obstructive
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with NET x Orexin receptor
NCT04645524
/ CompletedPhase 2
Phase 2 Randomized, Double Blind, Placebo-Controlled, Single-Dose, 3-Period Crossover Study to Evaluate the Efficacy of AD182, and AD504 in Obstructive Sleep Apnea
100 Clinical Results associated with NET x Orexin receptor
Login to view more data
100 Translational Medicine associated with NET x Orexin receptor
Login to view more data
0 Patents (Medical) associated with NET x Orexin receptor
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free